Logo-jcvtr

J Cardiovasc Thorac Res. 2017;9(3): 127-132. doi: 10.15171/jcvtr.2017.22
PMID: 29118944        PMCID: PMC5670333

Review Article

Cardiac progenitor cells application in cardiovascular disease

Hassan Amini 1,2, Jafar Rezaie 1, Armin Vosoughi 3, Reza Rahbarghazi 1,4 * , Mohammad Nouri 1 *

Cited by CrossRef: 37

1- Hassanpour M, Fathi Karkan S, Rahbarghazi R, Nouri M, Amini H, Saghati S, Baradar Khoshfetrat A. Culture of rabbit bone marrow mesenchymal stem cells on polyurethane/pyrrole surface promoted differentiation into endothelial lineage. Artificial Organs. 2021;45(9) [Crossref]
2- Yee-Goh A, Yamauchi A, van Hout I, Bellae Papannarao J, Sugunesegran R, Parry D, Davis P, Katare R. Cardiac Progenitor Cells and Adipocyte Stem Cells from Same Patients Exhibit In Vitro Functional Differences. IJMS. 2022;23(10):5588 [Crossref]
3- Hutchings G, Nawrocki M, Mozdziak P, Kempisty B. Cardiac Stem Cell Therapy, Resident Progenitor Cells and the role of Cellular Signalling; a Review. 2019;7(3):112 [Crossref]
4- Guerricchio L, Barile L, Bollini S. Evolving Strategies for Extracellular Vesicles as Future Cardiac Therapeutics: From Macro- to Nano-Applications. IJMS. 2024;25(11):6187 [Crossref]
5- Kalhori D, Zakeri N, Zafar-Jafarzadeh M, Moroni L, Solati-Hashjin M. Cardiovascular 3D bioprinting: A review on cardiac tissue development. Bioprinting. 2022;28:e00221 [Crossref]
6- Jahng J, Wu J. Cardiac reprogramming via chromatin remodeling by CRISPR activation. Molecular Therapy. 2022;30(1):6 [Crossref]
7- Tan K, Chang T, Lin X. Secretomes as an emerging class of bioactive ingredients for enhanced cosmeceutical applications. Experimental Dermatology. 2022;31(5):674 [Crossref]
8- Saheera S, Jani V, Witwer K, Kutty S. Extracellular vesicle interplay in cardiovascular pathophysiology. American Journal of Physiology-Heart and Circulatory Physiology. 2021;320(5):H1749 [Crossref]
9- Kuraitis D, Hosoyama K, Blackburn N, Deng C, Zhong Z, Suuronen E. Functionalization of soft materials for cardiac repair and regeneration. Critical Reviews in Biotechnology. 2019;39(4):451 [Crossref]
10- Portillo-Lara R, Spencer A, Walker B, Shirzaei Sani E, Annabi N. Biomimetic cardiovascular platforms for in vitro disease modeling and therapeutic validation. Biomaterials. 2019;198:78 [Crossref]
11- Zhu D, Li Z, Huang K, Caranasos T, Rossi J, Cheng K. Minimally invasive delivery of therapeutic agents by hydrogel injection into the pericardial cavity for cardiac repair. Nat Commun. 2021;12(1) [Crossref]
12- Khaksar M, Sayyari M, Rezaie J, Pouyafar A, Montazersaheb S, Rahbarghazi R. High glucose condition limited the angiogenic/cardiogenic capacity of murine cardiac progenitor cells in in vitro and in vivo milieu. Cell Biochemistry & Function. 2018;36(7):346 [Crossref]
13- Pahlavan S, Abrishami S. Upgrading treatment strategies of cardiovascular diseases using biotechnology: Are we still there?. J Cardiovasc Thorac Res. 2021;13(1):90 [Crossref]
14- Hassanpour M, Aghamohamadzade N, Cheraghi O, Heidarzadeh M, Nouri M. Current status of cardiac regenerative medicine; An update on point of view to cell therapy application. J Cardiovasc Thorac Res. 2020;12(4):256 [Crossref]
15- Nguyen B, Azam T, Wang X. Cellular signaling cross-talk between different cardiac cell populations: an insight into the role of exosomes in the heart diseases and therapy. American Journal of Physiology-Heart and Circulatory Physiology. 2021;320(4):H1213 [Crossref]
16- Sacco A, Castaldo C, Di Meglio F, Nurzynska D, Palermi S, Spera R, Gnasso R, Zinno G, Romano V, Belviso I. The Long and Winding Road to Cardiac Regeneration. Applied Sciences. 2023;13(16):9432 [Crossref]
17- Astinfeshan M, Rasmi Y, Kheradmand F, Karimipour M, Rahbarghazi R, Aramwit P, Nasirzadeh M, Daeihassani B, Shirpoor A, Gholinejad Z, Saboory E. Curcumin inhibits angiogenesis in endothelial cells using downregulation of the PI3K/Akt signaling pathway. Food Bioscience. 2019;29:86 [Crossref]
18- Feng Y, Wang Y, Li L, Yang Y, Tan X, Chen T. Exosomes Induce Crosstalk Between Multiple Types of Cells and Cardiac Fibroblasts: Therapeutic Potential for Remodeling After Myocardial Infarction. IJN. 2024;Volume 19:10605 [Crossref]
19- Albericio G, Aguilar S, Torán J, Yañez R, López J, Vázquez J, Mora C, Bernad A. Comparative proteomic analysis of nuclear and cytoplasmic compartments in human cardiac progenitor cells. Sci Rep. 2022;12(1) [Crossref]
20- Um J, Lee J, Jung D, Williams D. Re-education begins at home: an overview of the discovery of in vivo-active small molecule modulators of endogenous stem cells. Expert Opinion on Drug Discovery. 2018;13(4):307 [Crossref]
21- Jang W, Ji S, Park J, Kim Y, Kang S, Kim D, Lee N, Kim J, Lim H, Choi J, Le T, Ly T, Rethineswaran V, Kim D, Ha J, Yun J, Baek S, Kwon S. Engineered M13 Peptide Carrier Promotes Angiogenic Potential of Patient-Derived Human Cardiac Progenitor Cells and In Vivo Engraftment. Tissue Eng Regen Med. 2020;17(3):323 [Crossref]
22- Amini H, Hashemzadeh S, Heidarzadeh M, Mamipour M, Yousefi M, Saberianpour S, Rahbarghazi R, Nouri M, Sokullu E. Cytoprotective and cytofunctional effect of polyanionic polysaccharide alginate and gelatin microspheres on rat cardiac cells. International Journal of Biological Macromolecules. 2020;161:969 [Crossref]
23- Amini H, Namjoo A, Narmi M, Mardi N, Narimani S, Naturi O, Khosrowshahi N, Rahbarghazi R, Saghebasl S, Hashemzadeh S, Nouri M. Exosome-bearing hydrogels and cardiac tissue regeneration. Biomater Res. 2023;27(1) [Crossref]
24- Izadpanah M, Rahbarghazi R, Seghinsara A, Abedelahi A. Novel Approaches Used in Ovarian Tissue Transplantation for Fertility Preservation: Focus on Tissue Engineering Approaches and Angiogenesis Capacity. Reprod Sci. 2023;30(4):1082 [Crossref]
25- Barreto S, Hamel L, Schiatti T, Yang Y, George V. Cardiac Progenitor Cells from Stem Cells: Learning from Genetics and Biomaterials. Cells. 2019;8(12):1536 [Crossref]
26- Estrada-Meza C, Torres-Copado A, Loreti González-Melgoza L, Ruiz-Manriquez L, De Donato M, Sharma A, Pathak S, Banerjee A, Paul S. Recent insights into the microRNA and long non-coding RNA-mediated regulation of stem cell populations. 3 Biotech. 2022;12(10) [Crossref]
27- Andrade D, Oliveira G, Menezes L, Nascimento A, Carvalho S, Stumbo A, Thole A, Garcia-Souza É, Moura A, Carvalho L, Cortez E. Insulin-like growth factor-1 short-period therapy improves cardiomyopathy stimulating cardiac progenitor cells survival in obese mice. Nutrition, Metabolism and Cardiovascular Diseases. 2020;30(1):151 [Crossref]
28- Militello G, Bertolaso M. Stem Cells and the Microenvironment: Reciprocity with Asymmetry in Regenerative Medicine. Acta Biotheor. 2022;70(4) [Crossref]
29- Ghaleh A, Saghati S, Rahbarghazi R, Hassani A, Kaleybar L, Geranmayeh M, Hassanpour M, Rezaie J, Soltanzadeh H. Static and dynamic culture of human endothelial cells encapsulated inside alginate-gelatin microspheres. Microvascular Research. 2021;137:104174 [Crossref]
30- Fathi E, Valipour B, Vietor I, Farahzadi R. An Overview of the Myocardial Regeneration Potential of Cardiac c-Kit + Progenitor Cells Via PI3K and Mapk Signaling Pathways . Future Cardiol. 2020;16(3):199 [Crossref]
31- Franco D, Lozano-Velasco E. Healing the Broken Hearts: A Glimpse on Next Generation Therapeutics. Hearts. 2022;3(4):96 [Crossref]
32- Hassanpour M, Rezaie J, Darabi M, Hiradfar A, Rahbarghazi R, Nouri M. Autophagy modulation altered differentiation capacity of CD146+ cells toward endothelial cells, pericytes, and cardiomyocytes. Stem Cell Res Ther. 2020;11(1) [Crossref]
33- Bagheri H, Bani F, Tasoglu S, Zarebkohan A, Rahbarghazi R, Sokullu E. Mitochondrial donation in translational medicine; from imagination to reality. J Transl Med. 2020;18(1) [Crossref]
34- Haiaty S, Rashidi M, Akbarzadeh M, Bazmani A, Mostafazadeh M, Nikanfar S, Zibaei Z, Rahbarghazi R, Nouri M. Thymoquinone inhibited vasculogenic capacity and promoted mesenchymal-epithelial transition of human breast cancer stem cells. BMC Complement Med Ther. 2021;21(1) [Crossref]